NFKB1 and Disorder of lipid metabolism: This study found that PU alleviated HFD-induced glucose and lipid metabolic disorders, changed gut microbiota composition, inhibited the IKKβ/NF-κB signaling pathway and inflammatory cytokine secretion, and induced liver autophagy, which might be the crucial mechanism to attenuate HFD-induced insulin resistance.